Anal canal cancer in Brazil: why should we pay more attention to the epidemiology of this rare disease?

7 May 2020
Mauro DS Donadio, Rachel P Riechelmann

Anal canal cancer is one of the human papilloma virus (HPV)-associated diseases with increasing incidence. High-risk sexual behaviour and the resurgence of human immunodeficiency virus (HIV) infection, associated with low HPV vaccine coverage, are risk factors for the increased incidence of this cancer. In this paper, the authors point out pertinent questions regarding the greater exposure of the population to some risk factors and discuss the latest epidemiological data of these factors, particularly those of concern to emerging countries like Brazil. The authors also discuss policies adopted that have not been successful to combat the HIV and HPV rise and that have direct consequences on the incidence of anal canal cancer.

Related Articles

Lucky E Tietie, Kehinde S Okunade, Adaiah P Soibl-Harry, Sarah O John-Olabode, Rose I Anorlu
Joaquin Fernandez-Alberti, Matías Mihura Irribarra, Agustín Rancati, Nicolas Panzardi, Maria Florencia Cora, Daniela Speisky, Daniel Enrique Pirchi
Jhajaira M Araujo, Andrea C Gómez, Winston Zingg-De Jongh, Jhon Ausejo, Iván Córdova, Luis J Schwarz, Denisse Bretel, Williams Fajardo, Luis G Saravia-Huarca, Joshuan Barboza-Meca, Zaida Morante, Jaun R Guillén, Henry Gómez, Nadezhda K Cárdenas, Lady Hernández, Walter Melo, Cynthia Villarreal-Garza, Christian Caglevic, Carolina Palacio, Héctor García, Gerson Mejía, Claudio Flores, Carlos Vallejos, Joseph A Pinto
Juan Francisco Olivos-Gonzales, Elily Apumayta-Requena, Andrés Guevara-Jabiles, Mercedes Bravo-Taxa
Rodrigo Motta Guerrero, Veronica Arnao Labajos, Sophia Lozano Ballena, Carlos Aliaga Macha, Miguel Sotelo Lezama, Cristian Pacheco Roman, Paola Montenegro Beltran, Alejandro Figueroa Torrejon